−21.47USD
−637.32 MUSD
2.67 BUSD
19.69 M
About Bio-Rad Laboratories, Inc.
Sector
Industry
CEO
Norman D. Schwartz
Website
Headquarters
Hercules
Employees (FY)
8.03 K
Founded
1952
ISIN
US0905722072
FIGI
BBG000DY28W5
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of BIO is 281.02 USD — it has decreased by 3.38% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Bio-Rad Laboratories, Inc. stocks are traded under the ticker BIO.
Bio-Rad Laboratories, Inc. is going to release the next earnings report on Apr 25, 2024. Keep track of upcoming events with our Earnings Calendar.
BIO stock is 8.16% volatile and has beta coefficient of 1.82. Check out the list of the most volatile stocks — is Bio-Rad Laboratories, Inc. there?
One year price forecast for Bio-Rad Laboratories, Inc. has a max estimate of 474.00 USD and a min estimate of 350.00 USD.
BIO earnings for the last quarter are 2.33 USD whereas the estimation was 2.78 USD which accounts for −16.25% surprise. Estimated earnings for the next quarter are 2.82 USD. See more details about Bio-Rad Laboratories, Inc. earnings.
Bio-Rad Laboratories, Inc. revenue for the last quarter amounts to 632.12 M USD despite the estimated figure of 689.50 M USD. In the next quarter revenue is expected to reach 685.00 M USD.
Yes, you can track Bio-Rad Laboratories, Inc. financials in yearly and quarterly reports right on TradingView.
BIO stock has fallen by 14.95% compared to the previous week, the month change is a 15.27% fall, over the last year Bio-Rad Laboratories, Inc. has showed a 41.02% decrease.
BIO net income for the last quarter is 349.71 M USD, while the quarter before that showed 106.26 M USD of net income which accounts for 229.12% change. Track more Bio-Rad Laboratories, Inc. financial stats to get the full picture.
Today Bio-Rad Laboratories, Inc. has the market capitalization of 8.29 B, it has decreased by 0.80% over the last week.
No, BIO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Bio-Rad Laboratories, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 8.03 K employees. See our rating of the largest employees — is Bio-Rad Laboratories, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Bio-Rad Laboratories, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Bio-Rad Laboratories, Inc. stock shows the sell signal. See more of Bio-Rad Laboratories, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Bio-Rad Laboratories, Inc. future price: according to them, BIO price has a max estimate of 474.00 USD and a min estimate of 350.00 USD. Read a more detailed Bio-Rad Laboratories, Inc. forecast: see what analysts think of Bio-Rad Laboratories, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Bio-Rad Laboratories, Inc. EBITDA is 589.27 M USD, and current EBITDA margin is 21.57%. See more stats in Bio-Rad Laboratories, Inc. financial statements.